FDA Focusing on Projects to Use AI, Shifting Inspections to State

The US Food and Drug Administration (FDA) is continuing to delegate inspection responsibilities to state-level agencies while simultaneously pursuing internal AI development projects.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.